Ozempic has benefits in patients with chronic kidney damage and obesity
They prove that the drug Ozempic to treat diabetes that helps you lose weight also reduces inflammation, kidney deterioration and the amount of protein in the urine in patients with chronic...
Spain treats the first patient with a drug that attacks the root of cancer
A Spanish patient has been the first in the world to be treated with a drug called AOP208 that fights cancer from its roots by attacking tumor stem cells with a...
A drug increases survival in patients with gastric cancer
Administering the drug Zolbetuximab along with chemotherapy to patients with advanced gastric cancer reduces the risk of disease progression and death by 29% by enhancing the immune response to eliminate cancer...
Ozempic therapy would eliminate the need for insulin in diabetics
People with type 2 diabetes could stop needing insulin thanks to a new therapy that combines the drug Ozempic with an innovative procedure that has repaired intestinal dysfunction in 86% of...
Available in Spain APO-go POD, new drug for advanced Parkinson’s
Patients with advanced Parkinson's disease will now have access to APO-go POD 5 mg/ml, a medication from the pharmaceutical company Italfarmaco indicated to treat motor fluctuations that are not sufficiently controlled.Parkinson's...
Ozempic Face, the hidden (and aging) face of the fashionable slimmer
Ozempic face is a collateral aesthetic effect of the use of the well-known weight loss drug that occurs due to the loss of facial fat associated with rapid weight loss and...
New therapy increases survival in metastatic breast cancer
A new treatment with the drug trastuzumab deruxtecan has been shown to significantly increase the survival of patients with advanced HER2-positive breast cancer and brain metastases, according to an international study.Patients...
Health extends financing for two drugs against breast cancer
Health has approved expanding the indications for the drugs Enhertu and Trodelvy, which were already authorized and financed for the treatment of metastatic breast cancer, so that other patients with the...
First novel antipsychotic approved for schizophrenia in decades
The FDA has approved the drug Cobenfy for the treatment of schizophrenia in the US. It is the first antipsychotic that acts on cholinergic receptors and not on dopamine, a novel...
Older migraine medications are more effective than newer ones
Triptans are the most effective treatment for acute migraines in adults, according to a study led by the University of Oxford, which indicates that these drugs are more effective than conventional...
Europe recommends that the mpox vaccine can be administered to adolescents
The European Medicines Agency (EMA) has recommended extending the indication for the smallpox and mpox virus vaccine Imvanex to include adolescents aged 12 to 17 years, after verifying its safety and...
Pollution and heat increase stroke cases as much as tobacco
Fatal stroke cases have increased by 70% globally between 1990 and 2021, according to a study that highlights the impact of obesity and high temperatures and highlights air pollution as a...
Depemokimab halves the rate of severe asthma exacerbations
A biologic drug from GSK (Depemokimab) administered twice a year has been shown to reduce the rate of eosinophilic asthma attacks by up to 54% over 52 weeks, also reducing hospitalizations.Severe...
Epilepsy drug shows promise for sleep apnea
Sulthiame, a drug treatment already used to treat epilepsy, is emerging as a promising option for people with obstructive sleep apnea who cannot tolerate CPAP, according to a clinical trial presented...
The first oral treatment for acute myeloid leukemia arrives in Spain
INAQOVI®, the first oral monotherapy treatment funded in Spain, for adult patients with newly diagnosed acute myeloid leukemia who are not candidates for standard induction chemotherapy, has landed in our country.Acute...
Europe approves Moderna’s mRNA vaccine against RSV for people over 60
The European Commission has approved the marketing of mRESVIA, an mRNA vaccine developed by Moderna to protect people over 60 years of age against respiratory syncytial virus (RSV), based on the...
Ozempic may reduce heart attack risk in obese people
The obesity drug semaglutide (Ozempic) may significantly reduce the risk of heart attacks and other serious cardiovascular events in overweight people, including patients with heart failure.The anti-obesity drug semaglutide – the...
Heart attacks and strokes decrease after COVID vaccination
The incidence of heart attacks and strokes was up to 10% lower after the first dose of the COVID-19 vaccine and up to 27% lower after a second dose, according to...
Arthritis drugs ease some symptoms of long COVID
A cause of persistent COVID respiratory symptoms has been discovered inside the lungs and a potential treatment has been identified to alleviate them using drugs already approved to combat rheumatoid arthritis.Long...
Europe does not approve the long-awaited Alzheimer’s drug lecanemab
The European Medicines Agency (EMA) has recommended against approving lecanemab (Leqembi) – already approved in the US – to treat early-stage Alzheimer's disease because the cognitive benefits do not outweigh the...
Lenacapavir, the first drug against multi-resistant HIV funded in Spain
Gilead's Lenacapavir becomes the first drug funded in Spain to combat multi-drug-resistant HIV after demonstrating that 83% of patients achieve virological suppression 52 weeks after starting treatment.The multinational pharmaceutical company Gilead...
Weight loss drugs like Ozempic may reduce cancer risk
The use of Ozempic and other drugs of the same type to treat diabetes and lose weight is associated with a lower risk of developing 10 types of obesity-related cancer, including...
FDA approves donanemab, the controversial early Alzheimer’s drug
Lilly's drug donanemab (Kisunla), which promises to slow cognitive decline in patients with early-stage Alzheimer's, has been approved by the FDA after years of delays. Learn how it works, how effective...
Ozempic and Wegovy use linked to rare blindness
People who take semaglutide (Ozempic or Wegovy) to treat diabetes or lose weight may be at increased risk of developing a rare, potentially blinding eye disease called nonarteritic anterior ischemic optic...
Talc is “probably carcinogenic to humans” according to IARC
The WHO's International Agency for Research on Cancer has evaluated the carcinogenic potential of talc and considers it probably carcinogenic to humans, associating it with an increased incidence of ovarian cancer.The...
Harvard reveals which antidepressants cause the most and least weight gain
A study analyzing the relationship between treatment with eight common antidepressants and weight gain shows which are associated with a greater likelihood of weight gain and which are associated with less...
First nasal spray containing adrenaline approved for allergic reactions
Eurneffy (epinephrine) is the first nasal spray containing adrenaline for the emergency treatment of severe allergic reactions, the European Medicines Agency (EMA) recommending its marketing in the European Union.Allergy is the...
This is Mounjaro, the King Kong of slimming products that lands in Spain
Lilly's revolutionary drug Mounjaro (tirzepatide) that helps control type 2 diabetes and lose weight will be available in Spanish pharmacies from July 1. Find out how it works, how much...
A weight loss drug, the first effective drug for sleep apnea
Tirzepatide, used to treat type 2 diabetes and obesity, could become the first effective drug therapy for obstructive sleep apnea, shown to improve the health and sleep of obese patients with...
A revolutionary drug to treat alopecia areata arrives in Spain
The first and only treatment indicated for severe alopecia areata in adults and adolescents aged 12 and older is now available in Spain after demonstrating its effectiveness in reducing the immune...
